Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial

Inclusion Criteria: * individuals who meet the diagnostic criteria of diabetes gastric paralysis. * individuals between the ages of 18 and 60 years. * individuals who meet blood glucose control standards: Fasting plasma glucose (FPG) ≤7. 8mmol/L; 2 hours plasma glucose (2hPG)≤13.6mmol/L. * individuals who suffered for more than 3 years. * individuals who treated with diet control or exercise or using hypoglycemic drug (except for α-glucosidase Inhibitor) on the basis of diet or exercise therapy and the dose stability must be last at least 3 months. * individuals who receive no other treatments in the first 3 months. * women who is at the age of childbearing age and take contraceptive measures. * individuals who voluntarily agree with a study protocol and sign a written informed consent. Exclusion Criteria: * individuals who have reflux esophagitis; * individuals who have gastroparesis after surgery; * individuals who have acute complications with ketoacidosis and nonketotic hyperosmolar coma; * individuals who have Acute cardiovascular and cerebrovascular diseases or Severe trauma or surgery, severe infection. Or who are pregnant or breastfeeding; * individuals who have a history disease of myocardial infarction, acute coronary syndrome or coronary revascularization; * individuals who have serious hepatobiliary disease, or AST and/or ALT 2 times greater than the upper limit of normal patients; * individuals with kidney damage, and serum creatinine exceeds 140umol/L; * individuals who have obvious blood system diseases (Any one of which can not be caught in line: Hb: male\<110g/L, women\<100g/L,WBC\<3.5×109/L,PLT\<80×109/L). * individuals who have a problem of blood press:SBP≥180mmHg,DPB≥100mmHg; * individuals who have cancer or other serious progressive wasting disease, and easy to infection and bleeding; * individuals who have peptic ulcer or other organic disease confirmed by esophagogastroduodenoscopy; * individuals unwilling to meet the testing and exacerbations,or have serious complications in the test; * individuals who have taking α-glucosidase inhibitor drug in the past four weeks.